Showing 2371-2380 of 3223 results for "".
- Penn Medicine Study Finds Missing One Eye Appointment Can Lead to Vision Loss in Elderlyhttps://modernod.com/news/penn-medicine-study-finds-missing-one-eye-appointment-can-lead-to-vision-loss-in-elderly/2477319/A Penn Medicine study discovered that missing one ophthalmology appointment within a 2-year period could cause dec
- Not All With AMD May Need Continuing Treatmenthttps://modernod.com/news/not-all-with-amd-may-need-continuing-treatment/2477294/A small number of patients with neovascular age-related macular degeneration (AMD) continue to maintain good vision years after cessation of anti-VEGF therapy, according to an analysis of trial results, as reported by Reuters. Howe
- Quantel Medical Receives FDA Approval for the Vitra 2 Laser for Retinal Photocoagulationhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-the-vitra-2-laser-for-retinal-photocoagulation/2477148/Quantel Medical announced that it has received approval from the FDA for the Vitra 2 photocoagulator. The Vitra 2 includes all the key elements of the Vitra photocoagulator and features a wide a range of improv
- Orbis International Calls for “All Eyes on 2020” and Preserving the Future of Visionhttps://modernod.com/news/orbis-international-calls-for-all-eyes-on-2020-and-preserving-the-future-of-vision/2476963/On the eve of World Sight Day, Orbis International is celebrating achievements of the eye health community over the past two decades, and warns of a projected global tripling in demand for eye care over the next 30 years. 2020 is a critical year for Orbis International and other leaders in
- Novartis Receives FDA Approval for Beovu for Wet AMDhttps://modernod.com/news/novartis-receives-fda-approval-for-beovu-for-wet-amd/2476953/Novartis announced that the FDA approved Beovu (brolucizumab-dbll) injection, also known as RTH258, for the treatment of wet age-related macular degeneration (AMD). Beovu is the first FDA approved anti-VEGF to offer both greater fluid resolution versus aflibercept and the ability to maintain elig
- On World Sight Day, Orbis International Calls for “All Eyes on 2020” and Preserving the Future of Visionhttps://modernod.com/news/on-world-sight-day-orbis-international-calls-for-all-eyes-on-2020-and-preserving-the-future-of-vision/2476936/Today, Orbis International commemorates World Sight Day by celebrating achievements of the eye health community over the past two decades, and warning of a projected global tripling of blindness over the next 30 years. Next year is a critical year for Orbis International and other leaders
- B+L Introduces FreeFlow Infusion System and 23-Gauge Bi-Blade Dual Port Vitrectomy Cutterhttps://modernod.com/news/bausch-lomb-introduces-freeflow-infusion-system-for-retina-surgery/2476761/Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual port vitrectomy cutter for the Stellaris Elite vision enhancement system. The FreeFlow infusion system allows for higher level of infusion flow compared to previous generati
- Promedica International and Dr. Agarwal’s Eye Hospitals Form Strategic Alliancehttps://modernod.com/news/promedica-international-and-dr-agarwals-eye-hospitals-form-strategic-alliance/2476696/Promedica International (PMI) and Dr. Agarwal’s Eye Hospitals (AEH) have formed a new partnership to conduct clinical trials in India, which they announced at the OCTANe Ophthalmology Technology Summit. PMI and AEH em
- VSY Biotechnology is Now Accepting Applications for the “Ophthalmology Star Awards”https://modernod.com/news/vsy-biotechnology-is-now-accepting-applications-for-the-ophthalmology-star-awards/2476689/The Stars of Ophthalmology will be selected among the applicants who have a scientific article published in an ophthalmology journal since January 2018, according to a VSY Biotechnology news release. The articles are required to be authored in English and already published in order to be eligible
- Eyepromise Introduces Screen Shield Pro All-Natural Eye Vitamin for Screen Time Protection for Adultshttps://modernod.com/news/eyepromise-introduces-screen-shield-pro-all-natural-eye-vitamin-for-screen-time-protection-for-adults/2476661/EyePromise announced the introduction of Screen Shield Pro to its premium eye vitamin line. EyePromise’s Screen Shield Pro is designed to protect and relieve the associated symptoms of digital eye strain of adults (ages 18 and up) who spend 8+ hours staring at digital screens while working, gami